These findings highlight the potential of H-LV-WWOX as a promising therapeutic strategy for bladder cancer, leveraging its ability to induce apoptosis and enhance the effects of TNF-α through ROS production. This evidence concerns the gene TNF and urinary bladder carcinoma.